SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-328040
Filing Date
2021-11-12
Accepted
2021-11-12 16:02:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d221420ds3.htm S-3 363604
2 EX-4.4 d221420dex44.htm EX-4.4 30048
3 EX-4.5 d221420dex45.htm EX-4.5 255880
4 EX-5.1 d221420dex51.htm EX-5.1 31931
5 EX-23.1 d221420dex231.htm EX-23.1 1697
6 GRAPHIC g221420g1111074316172.jpg GRAPHIC 4363
7 GRAPHIC g221420g42h54.jpg GRAPHIC 47748
  Complete submission text file 0001193125-21-328040.txt   751976
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-261019 | Film No.: 211403275
SIC: 2834 Pharmaceutical Preparations